Testing effectiveness (Phase 2)Study completedNCT00699881What this trial is testingStudy of Cetuximab to Treat Gastric CancerWho this might be right forGastric Cancer Fudan University 61
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363330What this trial is testingA Phase II Study of Utidelone With Toripalimab in Advanced Cervical CancerWho this might be right forCervical CancerRecurrentMetastatic Zhongnan Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT06031584What this trial is testingBL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal TumorsWho this might be right forHer2-positive/Low-expression Urinary and Digestive Tract Tumors Sichuan Baili Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)UnknownNCT04118933What this trial is testingPD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal CancerWho this might be right forColorectal Cancer Xu jianmin 40
Testing effectiveness (Phase 2)Study completedNCT04491955What this trial is testingPhase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal CancersWho this might be right forSmall Bowel CancersColorectal Cancers National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT00054015What this trial is testing3-AP in Treating Patients With Advanced Prostate CancerWho this might be right forProstate Cancer Vion Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00566332What this trial is testingTrial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström MacroglobulinemiaWho this might be right forWaldenström MacroglobulinemiaLymphoplasmacytic LymphomaSplenic Marginal Zone Lymphoma French Study Group on Chronic Lymphoid Leukemia 414
Early research (Phase 1)Ended earlyNCT06560632What this trial is testingPhase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Repare Therapeutics 26
Not applicableUnknownNCT06205732What this trial is testingA Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.Who this might be right forCarcinoma, Hepatocellular Qianfoshan Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05765032What this trial is testingStudy of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Suzhou Suncadia Biopharmaceuticals Co., Ltd. 220
Testing effectiveness (Phase 2)Ended earlyNCT00868114What this trial is testingDirect Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Leo W. Jenkins Cancer Center 24
Large-scale testing (Phase 3)Looking for participantsNCT06675214What this trial is testingUnder Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.Who this might be right forNasopharyngeal CarcinomaDe-escalation Therapy Sun Yat-sen University 586
Early research (Phase 1)Looking for participantsNCT06764316What this trial is testingA First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver CancerWho this might be right forHepatocellular Carcinoma Bayer 148
Testing effectiveness (Phase 2)Ended earlyNCT06924606What this trial is testingEvaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and ImmunotherapyWho this might be right forAdvanced NSCLC Shanghai Junshi Bioscience Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT01372384What this trial is testingTarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor MutationsWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 6
Early research (Phase 1)Ended earlyNCT02367352What this trial is testingAlisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsOvarian CancerSmall Cell Lung Cancer Millennium Pharmaceuticals, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT04212052What this trial is testingSplit-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Sun Yat-sen University 104
Testing effectiveness (Phase 2)Study completedNCT00151047What this trial is testingDocetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate CancerWho this might be right forProstate Cancer University of Michigan Rogel Cancer Center 15
Not applicableStudy completedNCT05487248What this trial is testingOn-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer PatientsWho this might be right forUnresectable Locally Advanced Colorectal CancerMetastatic Colorectal CancerCandidate for Third-line or Subsequent Lines of Therapy Jules Bordet Institute 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT06717126What this trial is testingA Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal MelanomaWho this might be right forUveal MelanomaOcular Melanoma iOnctura 85